We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTRS
3151
DELISTED
Partners Bancorp Common Stock
PTRS
$113K ﹤0.01%
+17,131
New +$119K
CWBR
3152
DELISTED
CohBar, Inc. Common Stock
CWBR
$113K ﹤0.01%
+2,443
New +$171K
SEAC
3153
DELISTED
Seachange International Inc
SEAC
$111K ﹤0.01%
+3,689
New +$173K
KODK icon
3154
Kodak
KODK
$983M
$107K ﹤0.01%
+48,060
New +$112K
CHGA
3155
Change Agents Corporation Common Stock
CHGA
$2.55M
$104K ﹤0.01%
364
PBR icon
3156
Petrobras
PBR
$116B
$104K ﹤0.01%
+12,600
New +$91.3K
SNFCA icon
3157
Security National Financial
SNFCA
$251M
$103K ﹤0.01%
+21,035
New +$90.9K
ULBI icon
3158
Ultralife
ULBI
$106M
$102K ﹤0.01%
+14,536
New +$106K
LNAI
3159
Lunai Bioworks
LNAI
$10.9M
$101K ﹤0.01%
300
NL icon
3160
NLI Holdings
NL
$317M
$100K ﹤0.01%
29,322
-160
-0.5% -$496
GRTX
3161
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$100K ﹤0.01%
+14,027
New +$149K
TGS icon
3162
Transportadora de Gas del Sur
TGS
$4.33B
$99K ﹤0.01%
17,600
+1,400
+9% +$7.14K
NMRD
3163
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$99K ﹤0.01%
+10,702
New +$76.4K
TLRY icon
3164
Tilray
TLRY
$622M
$92K ﹤0.01%
+1,298
New +$105K
SOLY
3165
DELISTED
Soliton, Inc.
SOLY
$89K ﹤0.01%
11,378
-39,987
-78% -$393K
WLL
3166
DELISTED
Whiting Petroleum Corporation
WLL
$89K ﹤0.01%
+1,053
New +$82.1K
CSCO icon
3167
PUT
Cisco
CSCO
$479B
$87K ﹤0.01%
+1,850,000
New +$81.1M
VEDL
3168
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$79K ﹤0.01%
14,089
-425
-3% -$2.01K
WPG
3169
DELISTED
Washington Prime Group Inc.
WPG
$75K ﹤0.01%
9,895
-122,627
-93% -$901K
AAPL icon
3170
PUT
Apple
AAPL
$4.57T
$74K ﹤0.01%
824,800
+671,200
+437% +$52M
VTVT icon
3171
vTv Therapeutics
VTVT
$139M
$69K ﹤0.01%
+772
New +$76.2K
LINX
3172
DELISTED
Linx S.A.
LINX
$68K ﹤0.01%
14,795
ASX icon
3173
ASE Group
ASX
$82.2B
$66K ﹤0.01%
14,585
-478
-3% -$2.04K
BXG
3174
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$66K ﹤0.01%
12,203
BBAR icon
3175
BBVA Argentina
BBAR
$3.49B
$58K ﹤0.01%
15,500
+100
+0.6% +$326

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.